Vitronectin receptor antagonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 403/00 (2006.01) A61K 31/33 (2006.01) A61K 31/395 (2006.01) A61K 31/415 (2006.01) A61K 31/55 (2006.01) A61K 31/675 (2006.01) C07D 223/16 (2006.01) C07D 235/14 (2006.01) C07D 235/16 (2006.01) C07D 243/14 (2006.01) C07D 401/06 (2006.01) C07D 401/12 (2006.01) C07D 401/14 (2006.01) C07D 403/12 (2006.01) C07D 403/14 (2006.01) C07D 405/14 (2006.01) C07D 409/12 (2006.01) C07D 413/12 (2006.01) C07D 417/12 (2006.01) C07D 471/04 (2006.01) C07D 487/04 (2006.01) C07D 491/04 (2006.01) C07D 491/056 (2006.01) C07D 49

Patent

CA 2193966

Compounds are disclosed which are vitronectin receptor antagonists useful in the treatment of osteoporosis. These compounds comprise a fibrinogen receptor antagonist template linked to a heterocyclic moiety.

L'invention concerne des composés constituant des antagonistes du récepteur de la vitronectine qui sont utiles dans le traitement de l'ostéoporose. Ces composés comprennent une matrice antagoniste de récepteur fibrinogène liée à une fraction hétérocyclique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Vitronectin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vitronectin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vitronectin receptor antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1480546

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.